Karl Dane WITTRUP,Cary Francis OPEL,Eric Franklin ZHU,Shuning GAI
申请号:
US14304438
公开号:
US20150017120A1
申请日:
2014.06.13
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The present invention provides a method of enhancing adoptive cell therapy (ACT) by administering an extended-pharmacokinetic (PK) interleukin (IL)-2 to a cancer subject receiving ACT, optionally in combination with a therapeutic antibody. Methods of treating cancer and promoting tumor regression are also provided.